- wellness@asiamedic.com.sg
- +6567898888
-
Mon - Fri: 8:30am - 5:30pm
Sat: 8:30am - 12:30pm
Sun & PH: Closed
News
News
Change - Announcement Of Appointment Of Alternate Non-Executive Director (Alternate Director To Mr Tan Soo Kiat)
BackJun 03, 2015
| Announcement Title | Change - Announcement of Appointment |
| Announcement Subtitle | APPOINTMENT OF ALTERNATE NON-EXECUTIVE DIRECTOR (Alternate Director to Mr Tan Soo Kiat) |
| Securities | ASIAMEDIC LIMITED (ASIAMED) |
| Date & Time of Broadcast | Jun 3, 2015 20:14 |
| Submitted By | Stanley Woo Group Financial Controller |
| Description | This announcement has been prepared by the Company and reviewed by the Company's sponsor, Xandar Capital Pte Ltd (the "Sponsor"), for compliance with the Listing Manual (Section B: Rules of Catalist) of the Singapore Exchange Securities Trading Limited (the "SGX-ST"). The Sponsor has not independently verified the contents of this announcement including the accuracy or completeness of any of the information disclosed or the correctness of any of the statements made, opinions expressed or reports contained in this announcement. This announcement has not been examined or approved by the SGX-ST. The SGX-ST and the Sponsor assume no responsibility for the contents of this announcement including the correctness of any of the statements made, opinions expressed or reports contained in this announcement. Contact person for the Sponsor: Ms Pauline Sim (Registered Professional, Xandar Capital Pte Ltd) Address: 3 Shenton Way, #24-02 Shenton House, Singapore 068805 Telephone number: (65) 6319 4954 |
| Appointment Details | |
| Date of appointment | Jun 3, 2015 |
| Name of person | Koh Boon How (Kenneth) |
| Age | 34 |
| Country of principal residence | Singapore |
| The Board's comments on this appointment | The Nominating Committee has reviewed the credentials and experience of Mr Koh and recommended his appointment as Non-Executive Director (Alternate Director) of the Company. The Board of Directors has accepted and approved his appointment based on the recommendation of the Nominating Committee. |
| Whether appointment is executive, and if so, the area of responsibility | The appointment is non-executive (Alternate Director) |
| Job title | Alternate Director to Mr Tan Soo Kiat, a Non-Executive Director of the Company |
| Familial relationship with any director and/or substantial shareholder of the listed issuer or of any of its principal subsidiaries | No |
| Conflict of interests (including any competing business) | No |
| Working experience and occupation(s) during the past 10 years | Mr Koh Boon How is currently the Deputy Chief Financial Officer of Luye Pharma Group Ltd, a company listed on the Stock Exchange of Hong Kong. Prior to Mr Koh joining Luye Pharma Group Ltd in February 2010 as the Group Finance Manager, he was with KPMG Malaysia from 2004 to 2006, when he was transferred to KPMG Singapore where he worked between 2006 and 2010. His last position held at KPMG Singapore was Audit Assistant Manager. |
| Shareholding interest in the listed issuer and its subsidiaries | No |
| Other Directorships | |
| Note: These fields are not applicable for announcements of appointments pursuant to Listing Rule 704(9) or Catalist Rule 704(8) | |
| Past (for the last 5 years) | Nil |
| Present | 1. Luye Medicals Group Pte. Ltd. 2. Luye Medicals Investments Pte. Ltd. 3. A-Bio Pharma Pte, Ltd. 4. Asiapharm Investment Ltd. 5. Luye Pharma Investments Pte. Ltd. 6. Asiapharm (Singapore) Pte. Ltd. 7. Luye Biotech (Singapore) Pte. Ltd. 8. Luye Group (Singapore) Pte. Ltd. 9. Nature Wise Health Care Pte. Ltd. 10. Asiapharm Biotech Pte. Ltd. 11. Asiapharm Biotech Sdn. Bhd. |
| Information Required Persuant To Listing Rule 704(7)(H) | |
| (a) Whether at any time during the past 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner? | No |
| (b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at any time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency? | No |
| (c) Whether there is any unsatisfied judgment against him? | No |
| (d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose? | No |
| (e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach? | No |
| (f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part? | No |
| (g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust? | No |
| (h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust? | No |
| (i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity? | No |
| (j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of:- | |
| (i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or | No |
| (ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or | No |
| (iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or | No |
| (iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust? | No |
| (k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued with any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere? | No |
| Information Required persuant to Listing Rule 704(7)(I) | |
| Note: Disclosure applicable to the appointment of Director only | |
| Any prior experience as a director of a listed company? | No |
| If yes, please provide full details | Mr Koh Boon How will be provided with appropriate briefings and training in his role and responsibilities as a director of a listed company |